Ikon aset - trading kripto, saham, dan emas di Pluang
Trading di Pluang
Satu platform untuk semua pasar
Download
Investasi
Fitur
BiayaKeamanan
Akademi
Lainnya
Pluang+

Perbedaan Harga & Kinerja Samcro Hyosung Adilestari Tbk. (ACRO) vs UBC Medical Indonesia Tbk. (LABS)

Samcro Hyosung Adilestari Tbk.
UBC Medical Indonesia Tbk.

Kinerja harga

Pergerakan harga dalam 24 jam terakhir

Statistik utama

Perbedaan Samcro Hyosung Adilestari Tbk. dan UBC Medical Indonesia Tbk.: Samcro Hyosung Adilestari Tbk. diperdagangkan di Rp60 (kapitalisasi pasar 208,16 M, volume 24 jam 9,55 jt), sedangkan UBC Medical Indonesia Tbk. diperdagangkan di Rp152 (kapitalisasi pasar 556,95 M, volume 24 jam 60,83 jt). Perbedaan utamanya: UBC Medical Indonesia Tbk. jauh lebih besar — sekitar 2,7× kapitalisasi pasar Samcro Hyosung Adilestari Tbk., dan UBC Medical Indonesia Tbk. lebih aktif diperdagangkan (60,83 jt vs 9,55 jt). Mana yang lebih baik tergantung tujuan investasimu.

ACROLABS
Kapitalisasi Pasar
208,16 M556,95 M
Volume
9,55 jt60,83 jt
Lot
95,5 rb608,34 rb
Perputaran
587,56 jt10,26 M
Harga Rata-rata
61,52168,64
Nilai Transaksi
587,56 jt10,26 M
Harga Ekuilibrium Indikatif
60152
Volume Ekuilibrium Indikatif
2 rb4,52 rb

Perbandingan imbal hasil

Imbal hasil berjalan pada periode standar

Berita terkini

Berita terbaru kedua aset

ACRO
Lihat detail
LABS
Lihat detail

Tentang Samcro Hyosung Adilestari Tbk.

PT Samcro Hyosung Adilestari Tbk (The Company) was established on Republic of Indonesia based on Deed of Establishment No. 265 dated July 21, 1989 by Yudo Paripurno, S.H., Notary in Jakarta.

Selengkapnya di halaman ACRO

Tentang UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Selengkapnya di halaman LABS